Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2006-10-20
2009-02-24
Bunner, Bridget E (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C435S069520, C435S070100, C435S320100, C435S325000, C435S471000, C536S023500, C424S085200
Reexamination Certificate
active
07495080
ABSTRACT:
Novel polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zcytor17, a novel cytokine receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The polynucleotides encoding zcytor17, are located on chromosome 5, and can be used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
REFERENCES:
patent: 5116964 (1992-05-01), Capon et al.
patent: 7064186 (2006-06-01), Sprecher et al.
patent: 2003/0096339 (2003-05-01), Sprecher et al.
patent: 2004/0142422 (2004-07-01), Sprecher et al.
patent: 2005/0214801 (2005-09-01), Sprecher et al.
patent: 2007/0048303 (2007-03-01), Sprecher et al.
patent: 2007/0048307 (2007-03-01), Sprecher et al.
patent: 2007/0048308 (2007-03-01), Sprecher et al.
patent: 2007/0048309 (2007-03-01), Sprecher et al.
patent: 2007/0049527 (2007-03-01), Sprecher et al.
patent: 2007/0049528 (2007-03-01), Sprecher et al.
patent: 2007/0105777 (2007-05-01), Sprecher et al.
patent: 2007/0141051 (2007-06-01), Sprecher et al.
patent: 118830 (2002-03-01), None
patent: WO 00/75314 (2000-12-01), None
patent: WO 02/00690 (2002-01-01), None
patent: WO 02/00721 (2002-01-01), None
patent: WO 02/08288 (2002-01-01), None
patent: WO 02/29060 (2002-04-01), None
patent: WO 02/077230 (2002-10-01), None
Ghilardi et al (J. Biol. Chem., vol. 277, Issue 19, 16831-16836, May 10, 2002.
Diveu et al (J. Biol. Chem., vol. 278, Issue 50, 49850-49859, Dec. 12, 2003).
Bazan, “Structurual design and molecular evolution of a cytokine receptor superfamily,”Proc. Natl. Acad. Sci. USA, 87:6934-6938 (Sep. 1990).
Ghilardi et al., “A Novel Type I Cytokine Receptor Is Expressed on Monocytes, Signals Proliferation, and Activates STAT-3 and STAT-5,”J. Biol. Chem., 277(19):16831-16836 (May 10, 2002).
Mahairas et al., “Sequence-tagged connectors: A sequence approach to mapping and scanning the human genome,”Proc. Natl. Acad. Sci. USA, 96:9739-9744 (Aug. 1999).
Maeda et al., “Human haemopoietin receptor protein NR10.3 encoding cDNA SEQ ID No. 16,” GenBank Acc. No. AAC92350, Mar. 2001.
Maeda et al., “Human haemopoietin receptor protein NR10.3 SEQ ID No. 17,” GenBank Acc. No. AAB51244, Mar. 2001.
Zhang et al., “Homo sapiensCRL3 protein (CRL3) mRNA, complete cds,” GenBank Acc. No. AF106913, 2001.
Gao Zeren
Kuijper Joseph L.
Maurer Mark F.
Presnell Scott R.
Sprecher Cindy A.
Bunner Bridget E
Hamud Fozia M
Landes Jeffrey E.
Schutzer Aaron A.
Walsh Brian J.
LandOfFree
Cytokine receptor zcytor17 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytokine receptor zcytor17, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytokine receptor zcytor17 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4134500